Lilly Prepares For Zyprexa Expiration; Increases R&D Spend
Lilly's earnings are in line with analyst expectations, but higher costs cut into profits as the company prepares for a revenue decline.
Lilly's earnings are in line with analyst expectations, but higher costs cut into profits as the company prepares for a revenue decline.